Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $5.2M $4.6M $4.6M $6.5M $5.6M $3.1M $1.7M $964.5K
Cost of Revenue $931.0K $844.0K $508.0K $753.5K $547.9K $398.6K $300.8K $209.3K
Gross Profit $4.3M $3.8M $4.1M $5.7M $5.0M $2.7M $1.4M $755.2K
Gross Margin 82.1% 81.7% 88.9% 88.4% 90.2% 87.0% 82.3% 78.3%
Operating Expenses
Research & Development $100.0K $164.0K $922.7K $791.3K $1.1M $233.5K $54.9K
SG&A Expense $9.7M $9.1M $10.8M $14.6M $17.8M $15.1M $3.2M $4.2M
Operating Income $-5.4M $-5.3M $-6.8M $-8.8M $-12.7M $-12.4M $-1.8M $-3.5M
Operating Margin -103.6% -115.1% -148.5% -136.2% -227.7% -407.0% -104.4% -361.8%
Interest Expense $98.0K $92.0K $431.0K $398.3K $37.9K $177.7K $46.6K $228.3K
Pretax Income $-8.9M $-12.8M $-12.6M $-1.7M $-3.4M
Income Tax Expense $0 $0 $0 $0
Net Income $-5.5M $-4.7M $-7.0M $-8.9M $-12.8M $-12.6M $-1.7M $-3.5M
Net Margin -106.2% -101.8% -153.3% -137.1% -227.9% -411.8% -102.1% -358.9%
EPS (Basic) $-0.86 $-0.74 $-0.99 $-1.56 $-0.01 $-0.02 $0.00 $-0.01
EPS (Diluted) $-0.86 $-0.74 $-0.99 $-1.56 $-0.01 $-0.02 $0.00 $-0.01
Shares Outstanding (Basic) 6.4M 6.3M 7.0M 5.7M 1.13B 939.9M 502.9M 432.3M
Shares Outstanding (Diluted) 6.4M 6.3M 7.0M 5.7M 1.13B 939.9M 502.9M 432.3M
Dividends Per Share
← Newer Page 1 of 2 Older →